scispace - formally typeset
S

Stefan Schreiber

Researcher at University of Kiel

Publications -  1402
Citations -  155594

Stefan Schreiber is an academic researcher from University of Kiel. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 178, co-authored 1233 publications receiving 138528 citations. Previous affiliations of Stefan Schreiber include Washington University in St. Louis & University of Bologna.

Papers
More filters
Journal ArticleDOI

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Luke Jostins, +105 more
- 01 Nov 2012 - 
TL;DR: A meta-analysis of Crohn’s disease and ulcerative colitis genome-wide association scans is undertaken, followed by extensive validation of significant findings, with a combined total of more than 75,000 cases and controls.
Journal ArticleDOI

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

TL;DR: Patients with Crohn's disease who respond to an initial dose of infliximab are more likely to be in remission at weeks 30 and 54, to discontinue corticosteroids, and to maintain their response for a longer period of time, if inflIXimab treatment is maintained every 8 weeks.
Journal ArticleDOI

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

Elizabeth K. Speliotes, +413 more
- 01 Nov 2010 - 
TL;DR: Genetic loci associated with body mass index map near key hypothalamic regulators of energy balance, and one of these loci is near GIPR, an incretin receptor, which may provide new insights into human body weight regulation.
Journal ArticleDOI

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer, +265 more
- 10 Aug 2011 - 
TL;DR: In this article, a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, they have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci.